试从健康权角度论世界贸易组织体系的药品知识产权制度  

Study on pharmaceutical intellectual property system in WTO from angle of right to health

作　　者：范文舟[1] 

机构地区：[1]北方民族大学法学院,宁夏银川750021

出　　处：《中国新药与临床杂志》2015年第3期176-179,共4页Chinese Journal of New Drugs and Clinical Remedies

摘　　要：《与贸易有关的知识产权协定》(TRIPS)、《多哈宣言》和《执行多哈宣言第6段的决议》三个WTO体系的法律文件规定了保护药品知识产权和发展中国家公众健康权关系的处理原则和方法。TRIPS协议率先对药品知识产权做出了规定,但对发展中国家公众健康权仅仅做了原则性规定;《多哈宣言》对健康权更为强调,并做出了较为系统的规定(尤其是第6段);《执行多哈宣言第6段的决议》则对《多哈宣言》所确立的原则性规定进行了具体化阐述。The Agreement on Trade- Related Aspects of Intellectual Property Rights （TRIPS） , Doha Declaration, and the Resolutions of Implementation of the Sixth Paragraph of the Doha Declaration regulate principles and methods of protecting pharmaceutical intellectual property and the right to health of the public in developing countries. The TRIPS takes the lead in the pharmaceutical intellectual property rules, but it just provides principles for protecting public health rights. The right to health is more emphasized and systemized （especially in the sixth paragraph） in Doha Declaration. The Resolutions of Implementation of the Sixth Paragraph of the Doha Declaration embodies the principle rules established by Doha Declaration.

关 键 词：知识产权 健康权 世界卫生组织 立法 药物 

分 类 号：R951[医药卫生—药学]